Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Accounts Payables: 2016-2024

  • AC Immune's Accounts Payables rose 60.30% to $3.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.0 million, marking a year-over-year increase of 60.30%. This contributed to the annual value of $3.0 million for FY2024, which is 60.30% up from last year.
  • AC Immune's Accounts Payables amounted to $3.0 million in Q4 2024, which was up 60.30% from $1.9 million recorded in Q4 2023.
  • AC Immune's 5-year Accounts Payables high stood at $3.0 million for Q4 2024, and its period low was $964,322 during Q4 2022.
  • For the 3-year period, AC Immune's Accounts Payables averaged around $2.0 million, with its median value being $1.9 million (2023).
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 1,583.81% in 2020, then plummeted by 55.61% in 2022.
  • Over the past 5 years, AC Immune's Accounts Payables (Quarterly) stood at $2.4 million in 2020, then fell by 10.08% to $2.2 million in 2021, then plummeted by 55.61% to $964,322 in 2022, then surged by 96.29% to $1.9 million in 2023, then soared by 60.30% to $3.0 million in 2024.
  • Its last three reported values are $3.0 million in Q4 2024, $1.9 million for Q4 2023, and $964,322 during Q4 2022.